BlueCrest Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-7,715
| Closed | -$652K | – | 216 |
|
|
2020
Q1 | $652K | Buy |
7,715
+2,000
| +35% | +$169K | 0.04% | 116 |
|
|
2019
Q4 | $483K | Sell |
5,715
-600
| -10% | -$50.7K | 0.03% | 197 |
|
|
2019
Q3 | $426K | Buy |
6,315
+2,500
| +66% | +$169K | 0.03% | 282 |
|
|
2019
Q2 | $327K | Buy |
+3,815
| New | +$327K | 0.02% | 258 |
|
|
2018
Q4 | – | Sell |
-2,684
| Closed | -$260K | – | 886 |
|
|
2018
Q3 | $260K | Buy |
2,684
+454
| +20% | +$44K | 0.01% | 1096 |
|
|
2018
Q2 | $210K | Buy |
+2,230
| New | +$210K | 0.01% | 1257 |
|
|
2017
Q4 | – | Sell |
-5,347
| Closed | -$498K | – | 834 |
|
|
2017
Q3 | $498K | Sell |
5,347
-3,203
| -37% | -$298K | 0.02% | 503 |
|
|
2017
Q2 | $777K | Hold |
8,550
| – | – | 0.03% | 490 |
|
|
2017
Q1 | $751K | Hold |
8,550
| – | – | 0.04% | 348 |
|
|
2016
Q4 | $708K | Sell |
8,550
-7,154
| -46% | -$592K | 0.04% | 389 |
|
|
2016
Q3 | $1.45M | Buy |
15,704
+4,604
| +41% | +$426K | 0.05% | 302 |
|
|
2016
Q2 | $864K | Buy |
+11,100
| New | +$864K | 0.04% | 363 |
|
|
2016
Q1 | – | Sell |
-2,228
| Closed | -$233K | – | 725 |
|
|
2015
Q4 | $233K | Buy |
+2,228
| New | +$233K | 0.01% | 767 |
|
|
2015
Q3 | – | Sell |
-17,400
| Closed | -$2.38M | – | 784 |
|
|
2015
Q2 | $2.38M | Buy |
+17,400
| New | +$2.38M | 0.07% | 253 |
|
|
2014
Q4 | – | Sell |
-37,400
| Closed | -$2.7M | – | 505 |
|
|
2014
Q3 | $2.7M | Buy |
+37,400
| New | +$2.7M | 0.1% | 169 |
|